New Britain, PA, United States of America

Richard W Ransom


Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 222(Granted Patents)


Location History:

  • New Britian, PA (US) (1993 - 1997)
  • New Britain, PA (US) (1993 - 2002)

Company Filing History:


Years Active: 1993-2002

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Richard W Ransom

Introduction

Richard W Ransom is a notable inventor based in New Britain, PA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work primarily focuses on the development of novel compounds and receptors that have potential therapeutic applications.

Latest Patents

One of Ransom's latest patents is for the cloned and expressed human bradykinin BK-2 receptor. This invention involves a cloned human BK-2 bradykinin receptor derived from a human lung fibroblast cell line. The cDNA clone encodes a novel 364 amino acid protein that exhibits the characteristics of a seven transmembrane domain G-protein coupled receptor. This invention is instrumental in expressing a BK-2 bradykinin receptor in host mammalian cells, facilitating the screening for pharmaceutical antagonists or agonists that interact with the BK-2 bradykinin receptor protein.

Another significant patent is related to muscarine antagonists. This invention focuses on novel 1,3-dihydro-1-[(1-heteroarylpiperidin-4-yl)piperidin-4-yl]-2H-benzimidazolones and their derivatives. These compounds possess antimuscarinic activity and are useful in the treatment and prevention of myopia, commonly known as nearsightedness.

Career Highlights

Richard W Ransom is associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Ransom has collaborated with notable colleagues, including Pierre J Mallorga and Michael F Sugrue. These collaborations have further enhanced the impact of his inventions in the field.

Conclusion

Richard W Ransom's innovative work in the pharmaceutical sector demonstrates his commitment to advancing medical science. His patents reflect a deep understanding of biochemistry and a dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…